Search in:

Clinical Ophthalmology Volume 10, 2016 - Issue

Submit an article Journal homepage

Open access

158

Views

CrossRef citations to date

Altmetric

Original Research

Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials

Pravin U Dugel1 Retinal Consultants of Arizona LTD, Retinal Research Institute LLC, Phoenix, AZ, USA;2 USC Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USACorrespondence[email protected]

Jost Hillenkamp3 Department of Ophthalmology, Julius-Maximilians University, Würzburg, Germany

Sobha Sivaprasad4 NIHR Biomedical Research Centre, Moorfields Eye Hospital, London;5 King’s College Hospital, London, UK

Jessica Vögeler6 Novartis Pharma GmbH, Nürnberg, Germany

Marie-Catherine Mousseau7 Novartis Ireland Limited, Dublin, Ireland

Andreas Wenzel8 Novartis Pharma AG, Basel, Switzerland

Philippe Margaron8 Novartis Pharma AG, Basel, Switzerland

Ron Hashmonay8 Novartis Pharma AG, Basel, Switzerland

Pascale Massin9 Department of Ophthalmology, Hôpital Lariboisière, Assistance Publique des Hôpitaux de Paris, Université Paris Diderot, Paris, France

show all

Pages 1103-1110 | Published online: 14 Jun 2016

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

American Diabetic AssociationStandards of medical care in diabetes-2012Diabetes Care201235suppl 1S11S6322187469
PubMed Web of Science ®Google Scholar
FongDSAielloLPFerrisFL3rdKleinRDiabetic retinopathyDiabetes Care200427102540255315451934
PubMed Web of Science ®Google Scholar
KleinRKleinBEMossSEDavisMDDeMetsDLThe Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edemaOphthalmology19849112146414746521986
PubMed Web of Science ®Google Scholar
MitchellPBandelloFSchmidt-ErfurthURESTORE Study GroupThe RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edemaOphthalmology2011118461562521459215
PubMed Web of Science ®Google Scholar
ElmanMJAielloLPBeckRWRandomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edemaOphthalmology201011761064.e1077.e20427088
PubMed Web of Science ®Google Scholar
MassinPBandelloFGarwegJGSafety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II studyDiabetes Care201033112399240520980427
PubMed Web of Science ®Google Scholar
NguyenQDBrownDMMarcusDMRISE and RIDE Research GroupRanibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDEOphthalmology2012119478980122330964
PubMed Web of Science ®Google Scholar
DoDVNguyenQDBoyerDDA VINCI Study GroupOne-year outcomes of the DA VINCI Study of VEGF Trap-Eye in eyes with diabetic macular edemaOphthalmology201211981658166522537617
PubMed Web of Science ®Google Scholar
KorobelnikJFDoDVSchmidt-ErfurthUIntravitreal aflibercept for diabetic macular edemaOphthalmology20141212247225425012934
PubMed Web of Science ®Google Scholar
PrunteCFajnkuchenFMahmoodSthe RETAIN Study GroupRanibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN studyBr J Ophthalmol Epub2015109
Web of Science ®Google Scholar
MitchellPChongVBaseline predictors of 3-year responses to ranibizumab and laser therapy in patients with visual impairment due to diabetic macular edema – The RESTORE study predictors analysisePoster presented at: 13th EURETINA CongressSeptember 26–29, 2013Hamburg
Google Scholar
BresslerSBQinHBeckRWDiabetic Retinopathy Clinical Research NetworkFactors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumabArch Ophthalmol201213091153116122965591
PubMedGoogle Scholar
SivaprasadSFajnkuchenFRégnierSAWrightJLarsenMUsing patient-level data for meaningful cross-trial comparisons in the visual impairment due to diabetic macular edema treated with anti-VEGF agentsPoster presented at: The Association for Research in Vision and Ophthalmology (ARVO) MeetingMay 3–7, 2015Denver
Google Scholar
BoyerDSHopkinsJJSorofJEhrlichJSAnti-vascular endothelial growth factor therapy for diabetic macular edemaTher Adv Endocrinol Metab20134615116924324855
PubMedGoogle Scholar
MarzecLNMaddoxTMMedication adherence in patients with diabetes and dyslipidemia: associated factors and strategies for improvementCurr Cardiol Rep2013151141824057772
PubMed Web of Science ®Google Scholar
WellsJAGlassmanARAyalaARAflibercept, bevacizumab, or ranibizumab for diabetic macular edemaN Engl J Med2015372131193120325692915
PubMed Web of Science ®Google Scholar
SignorovitchJESikiricaVErderMHMatching-adjusted indirect comparisons: a new tool for timely comparative effectiveness researchValue Health201215694094722999145
PubMed Web of Science ®Google Scholar
European Medicines Agency [webpage on the Internet]Lucentis: EPAR-Product Information EMEA/H/C/000715-IB/0032 [updated November 13, 2015]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000715/WC500043546.pdfAccessed February 1, 2016
Google Scholar
FingerRPWickremasingheSSBairdPNGuymerRHPredictors of anti-VEGF treatment response in neovascular age-related macular degenerationSurv Ophthalmol201459111824332379
PubMed Web of Science ®Google Scholar
TufailAXingWJohnstonRThe neovascular age-related macular degeneration database: multicenter study of 92 976 ranibizumab injections: report 1: visual acuityOphthalmology201412151092110124461586
PubMed Web of Science ®Google Scholar
MichaelidesMKainesAHamiltonRDA prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2Ophthalmology201011761078.e1086.e20416952
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date